Amplo Biotechnology Inc.

San Diego, CA

UEI
H93DMA2RBMS1
CAGE
8PMP8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2223 Avenida De La Playa #108, La Jolla, CA 92037, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Targeted colq gene therapy for congenital myasthenic syndromes R42NS127713 National Institute of Neurological Disorders and Stroke (NIH) $5,306,216
Targeted DOK7 gene therapy for congenital myasthenic syndromes R44NS124351 National Institute of Neurological Disorders and Stroke (NIH) $12,739,517

Quick answers

Is Amplo Biotechnology Inc. registered in SAM.gov?

Yes. Amplo Biotechnology Inc.'s SAM.gov registration is active through February 23, 2027.

What is Amplo Biotechnology Inc.'s most recent federal award?

Amplo Biotechnology Inc.'s most recent federal grant award is Targeted colq gene therapy for congenital myasthenic syndromes (R42NS127713), from National Institute of Neurological Disorders and Stroke (NIH), on June 1, 2023.

On GovTribe

See Amplo Biotechnology Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login